AACR Journals
@aacrjournals.bsky.social
200 followers 28 following 180 posts
The American Association for Cancer Research’s 10 peer-reviewed journals provide a renowned, respected forum for publishing the most innovative cancer science, encompassing the full spectrum of basic, translational, clinical, and epidemiological research.
Posts Media Videos Starter Packs
aacrjournals.bsky.social
Check out this article in Cancer Immunology Research: buff.ly/wv7ZMSG

Using a CRISPR screen, the authors identify DYRK1A as a regulator of CD155 expression and show that targeting the PI3K/Akt pathway to reduce CD155 expression may help overcome resistance to PD-1 blockade in HNSCC.
aacrjournals.bsky.social
Certain patients’ risk of developing #breastcancer in the future may be predicted by a genetic risk score, according to a new study from Kings College London researchers in Cancer Epidemiology, Biomarkers & Prevention. Learn more: buff.ly/Kg1yeOA
aacrjournals.bsky.social
This study presents a novel genetic ancestry pipeline & applies it to assess model diversity in the PDXNet, identifying a need to diversify models for basic biological & precision medicine research.

Read the latest articles from this section: buff.ly/wh5gs5i
aacrjournals.bsky.social
Concluding our Article Showcase is a featured selection from Melissa B. Davis, Senior Editor of Health Disparities and Outcomes Research: “Genetic Ancestry in PDXNet Models” buff.ly/jBtUKTA
Reposted by AACR Journals
theaacr.bsky.social
A series of papers published in the AACR journal Clinical Cancer Research shared key considerations for how to improve dosage optimization in oncology. Learn more on the AACR Blog: buff.ly/ZFH90e3
aacrjournals.bsky.social
This study reports that females had a higher prevalence of specific comorbidities than males, suggesting that survivorship care should be tailored to age & gender for this common pediatric cancer.

Read the latest Epidemiology & Prevention articles: buff.ly/SRpmUtZ
aacrjournals.bsky.social
Next up in our Article Showcase is a featured selection from Joya Chandra, Senior Editor of Epidemiology and Prevention: “Age and Sex Differences in the Prevalence of Specific Comorbidities among Patients with Pediatric ALL and LL at Diagnosis” buff.ly/R3Vz7BX
aacrjournals.bsky.social
The authors report safety, tolerability, and efficacy data on sapanisertib in combination with metformin in patients with advanced solid tumors and mTOR/AKT/PI3K pathway alterations.

Read the latest Clinical Research and Trials articles: buff.ly/H3NDXiv
aacrjournals.bsky.social
Up next in our Article Showcase is a featured selection from Eileen M. O’Reilly, Senior Editor of Clinical Research and Trials: “Sapanisertib plus Metformin in Metastatic Solid Tumors” buff.ly/RlwT75M
aacrjournals.bsky.social
Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/O6OYSDp
aacrjournals.bsky.social
The authors explore a novel two-cutoff approach that allows for splitting of patients when a non-monotonic relationship is present, modeling more complex relationships of TMB to outcome data.

Read the latest Precision Medicine and Biomarkers articles: buff.ly/MhmDeBX
aacrjournals.bsky.social
The next featured selection in our Article Showcase is from Jakob N. Kather, Senior Editor of Precision Medicine and Biomarkers: “Characterization of Non-Monotonic Relationships between Tumor Mutational Burden and Clinical Outcomes” buff.ly/yheXp2g @jnkt.bsky.social
aacrjournals.bsky.social
The authors developed an ADC that targets fibroblast activation protein (FAP) and sought to understand the mechanism behind FAP-targeted therapies.

Read the latest Therapeutic Research and Development articles: buff.ly/DuaSTEm
aacrjournals.bsky.social
Next up in our Article Showcase is a featured selection from Alex Sparreboom, Senior Editor of Therapeutic Research and Development: “Mechanistic Characterization of CAF Depletion via an ADC Targeting Fibroblast Activation Protein” buff.ly/RuStSV4
aacrjournals.bsky.social
In this recent Cancer Immunology Research article, the authors show that elevated infiltration of SPP1+ TAMs is related to worse response to immunotherapy and to dysfunction of CD8+ T cells in ccRCC. The data suggest SPP1 as a potential therapeutic target in ccRCC.

Read more: buff.ly/kC0UJ7y
aacrjournals.bsky.social
Cancer Research Communications:

Methylation-Based ctDNA Tumor Fraction Changes Predict Long-Term Clinical Benefit From Immune Checkpoint Inhibitors in RADIOHEAD, a Real-World Pan-Cancer Study buff.ly/MOdpRuh
aacrjournals.bsky.social
Molecular Cancer Therapeutics:

The Discovery and Characterization of HBS-101, a Novel Inhibitor of Midkine, as a Therapeutic Agent for the Treatment of Triple-Negative Breast Cancer buff.ly/gr907TU
aacrjournals.bsky.social
Molecular Cancer Research:

Mitochondrial HSP90 Paralog TRAP1 Deletion Drives Glutamine Addiction in Tumor Cells via Destablization of the Cys/Glu Antiporter SLC7A11/xCT buff.ly/tuj6j8Y
aacrjournals.bsky.social
Clinical Cancer Research:

Cemiplimab for Secondary Angiosarcomas buff.ly/7JJLfp6

Tarlatamab in Neuroendocrine Prostate Cancer buff.ly/DmfN9QR
aacrjournals.bsky.social
Cancer Research:

Dietary Fiber Lacks a Consistent Effect on Immune Checkpoint Blockade Efficacy Across Diverse Murine Tumor Models buff.ly/8wlFWnG

Adaptive Therapy Exploits Fitness Deficits in Chemotherapy-Resistant Ovarian Cancer to Achieve Long-Term Tumor Control buff.ly/mRR1JJ4
aacrjournals.bsky.social
Cancer Prevention Research:

CervicalMethDx: A Precision DNA Methylation Test to Identify Risk of High-Grade Intraepithelial Lesions in Cervical Cancer Screening Algorithms buff.ly/istUE7m
aacrjournals.bsky.social
Cancer Immunology Research:

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies buff.ly/h0T7Ee9
aacrjournals.bsky.social
Cancer Epidemiology, Biomarkers and Prevention:

The Effect of Circulating Proteins and Their Role in Mediating Adiposity’s Effect on Endometrial Cancer Risk: Mendelian Randomization and Colocalization Analyses buff.ly/Ri1cjGE
aacrjournals.bsky.social
Cancer Discovery: Detection of Cancers Three Years prior to Diagnosis Using Plasma Cell-Free DNA buff.ly/ugnsVZI